126 related articles for article (PubMed ID: 37802315)
1. Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients.
Sahlström P; Joshua V; Valkovskaia V; Biese C; Stålesen R; Israelsson L; Végvári Á; Scheel-Toellner D; Klareskog L; Hansson M; Hensvold A; Malmström V; Grönwall C
J Biol Chem; 2023 Nov; 299(11):105320. PubMed ID: 37802315
[TBL] [Abstract][Full Text] [Related]
2. Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis.
Grönwall C; Amara K; Hardt U; Krishnamurthy A; Steen J; Engström M; Sun M; Ytterberg AJ; Zubarev RA; Scheel-Toellner D; Greenberg JD; Klareskog L; Catrina AI; Malmström V; Silverman GJ
J Autoimmun; 2017 Nov; 84():29-45. PubMed ID: 28647488
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
Front Immunol; 2021; 12():627986. PubMed ID: 34093522
[TBL] [Abstract][Full Text] [Related]
4. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.
Thiele GM; Duryee MJ; Anderson DR; Klassen LW; Mohring SM; Young KA; Benissan-Messan D; Sayles H; Dusad A; Hunter CD; Sokolove J; Robinson WH; O'Dell JR; Nicholas AP; Tuma DJ; Mikuls TR
Arthritis Rheumatol; 2015 Mar; 67(3):645-55. PubMed ID: 25417811
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.
Mikuls TR; Duryee MJ; Rahman R; Anderson DR; Sayles HR; Hollins A; Michaud K; Wolfe F; Thiele GE; Sokolove J; Robinson WH; Lingampalli N; Nicholas AP; Talmon GA; Su K; Zimmerman MC; Klassen LW; Thiele GM
Rheumatology (Oxford); 2017 Oct; 56(10):1794-1803. PubMed ID: 28957552
[TBL] [Abstract][Full Text] [Related]
6. Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
England BR; Duryee MJ; Roul P; Mahajan TD; Singh N; Poole JA; Ascherman DP; Caplan L; Demoruelle MK; Deane KD; Klassen LW; Thiele GM; Mikuls TR
Arthritis Rheumatol; 2019 Sep; 71(9):1483-1493. PubMed ID: 30933423
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.
Mikuls TR; Edison J; Meeshaw E; Sayles H; England BR; Duryee MJ; Hunter CD; Kelmenson LB; Kay Moss L; Feser ML; Wagner B; Parish MC; Deane KD; Thiele GM
Arthritis Rheumatol; 2020 Dec; 72(12):2025-2029. PubMed ID: 32621635
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.
van den Beukel MD; van Wesemael TJ; Hoogslag ATW; Borggreven NV; Huizinga TW; van der Helm-van Mil AH; Toes RE; van der Woude D; Trouw LA
RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053459
[TBL] [Abstract][Full Text] [Related]
9. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions.
Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM
Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640
[TBL] [Abstract][Full Text] [Related]
10. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression.
Rodriguez-Martinez L; García-Moreno C; Perez-Pampin E; Gómara MJ; Sarmiento-Monroy JC; Lopez-Golán Y; Gómez-Puerta JA; Mera-Varela A; Conde C; Sanmartí R; Haro I; González A
Arthritis Res Ther; 2023 Oct; 25(1):192. PubMed ID: 37798800
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis.
Lomzenski HE; Thiele GM; Duryee MJ; Chen SC; Ye F; Anderson DR; Mikuls TR; Ormseth MJ
Sci Rep; 2022 Jun; 12(1):10547. PubMed ID: 35732827
[TBL] [Abstract][Full Text] [Related]
12. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration.
Tuma DJ; Thiele GM; Xu D; Klassen LW; Sorrell MF
Hepatology; 1996 Apr; 23(4):872-80. PubMed ID: 8666344
[TBL] [Abstract][Full Text] [Related]
13. Malondialdehyde-Acetaldehyde (MAA) Protein Adducts Are Found Exclusively in the Lungs of Smokers with Alcohol Use Disorders and Are Associated with Systemic Anti-MAA Antibodies.
Sapkota M; Burnham EL; DeVasure JM; Sweeter JM; Hunter CD; Duryee MJ; Klassen LW; Kharbanda KK; Sisson JH; Thiele GM; Wyatt TA
Alcohol Clin Exp Res; 2017 Dec; 41(12):2093-2099. PubMed ID: 28941289
[TBL] [Abstract][Full Text] [Related]
14. Isotypes of autoantibodies against differentially expressed novel malondialdehyde-modified peptide adducts in serum of Taiwanese women with rheumatoid arthritis.
Liao CC; Chang YS; Cheng CW; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lin YF; Lin HT; Lu YY; Lin CY
J Proteomics; 2018 Jan; 170():141-150. PubMed ID: 28870784
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
Kononoff A; Hörkkö S; Pussinen P; Kautiainen H; Elfving P; Savolainen E; Arstila L; Niinisalo H; Rutanen J; Marjoniemi O; Kaipiainen-Seppänen O
Scand J Rheumatol; 2021 Mar; 50(2):113-117. PubMed ID: 32985314
[No Abstract] [Full Text] [Related]
16. Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging.
Zimmerman MC; Clemens DL; Duryee MJ; Sarmiento C; Chiou A; Hunter CD; Tian J; Klassen LW; O'Dell JR; Thiele GM; Mikuls TR; Anderson DR
Redox Biol; 2017 Oct; 13():588-593. PubMed ID: 28803127
[TBL] [Abstract][Full Text] [Related]
17. Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke.
McCaskill ML; Kharbanda KK; Tuma DJ; Reynolds JD; DeVasure JM; Sisson JH; Wyatt TA
Alcohol Clin Exp Res; 2011 Jun; 35(6):1106-13. PubMed ID: 21428986
[TBL] [Abstract][Full Text] [Related]
18. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.
Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR
Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441
[TBL] [Abstract][Full Text] [Related]
19. Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis.
Aripova N; Duryee MJ; England BR; Hunter CD; Mordeson JE; Ryan EM; Daubach EC; Romberger DJ; Thiele GM; Mikuls TR
Front Immunol; 2023; 14():1203548. PubMed ID: 37654483
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid Arthritis-Specific Autoimmunity in the Lung Before and at the Onset of Disease.
Joshua V; Loberg Haarhaus M; Hensvold A; Wähämaa H; Gerstner C; Hansson M; Israelsson L; Stålesen R; Sköld M; Grunewald J; Klareskog L; Grönwall C; Réthi B; Catrina A; Malmström V
Arthritis Rheumatol; 2023 Nov; 75(11):1910-1922. PubMed ID: 37192126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
